Blue-blocking intraocular implants should be used routinely during phacoemulsification surgery-Yes

Eye (Basingstoke)

Volumn 26, Issue 11, 2012, Pages 1397-1399

  Symes, R J ^a   Cuthbertson, F M ^a  

^a SUSSEX EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOPSIN;

AGING; ARTICLE; BLUE BLOCKING INTRAOCULAR IMPLANT; CIRCADIAN RHYTHM; COGNITION; HUMAN; IMPLANT; LENS; LENS IMPLANT; LIGHT EXPOSURE; MOOD; NONHUMAN; PATHOGENESIS; PHACOEMULSIFICATION; RETINA GANGLION CELL; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD; SENSITIVITY ANALYSIS; SLEEP WAKING CYCLE; ULTRAVIOLET RADIATION;

EID: 84869037172     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.178     Document Type: Article

References (18)

1. Cuthbertson FM, Peirson SN, Wulff K, Foster RG, Downes SM. Blue light-filtering intraocular lenses: review of potential benefits and side effects. J Cataract Refract Surg 2009; 35: 1281-1297.
2. Youssef PN, Sheibani N, Albert DM. Retinal light toxicity. Eye 2011; 25: 1-14.
3. Van Norren D, Gorgels T. The action spectrum of photochemical damage to the retina: a review of monochromatic threshold data. Photochem Photobiol 2011; 87: 747-753.
4. Hunter JJ, Morgan JIW, Merigan WH, Sliney DH, Sparrow JR, Williams DR. The susceptibility of the retina to photochemical damage from visible light. Prog Retin Eye Res 2012; 31: 28-42.
5. Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C, Chakravarthy U et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 2008; 126: 1396-1403.
6. Jackson GRC, Owsley MGJ. Aging and dark adaptation. Vision Res 1999; 39: 3975-3982.
7. Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 2004; 23: 523-531. (Pubitemid 39078360)
8. Pons A, Delgado D, Campos J. Determination of the action spectrum of the blue-light hazard for different intraocular lenses. J Opt Soc Am A Opt Image Sci Vis 2007; 24: 1545-1550. (Pubitemid 47045702)
9. Mainster MA, Sparrow JR. How much blue light should an IOL transmit? Br J Ophthalmol 2003; 87: 1523-1529. (Pubitemid 38010560)
10. Greenstein VC, Chiosi F, Baker P, Seiple W, Holopigian K, Braunstein RE et al. Scotopic sensitivity and color vision with a blue light-absorbing intraocular lens. J Cataract Refract Surg 2007; 33: 284-289.
11. Muftuoglu O, Karel F, Duman R. Effect of a yellow intraocular lens on scotopic vision, glare disability and blue color perception. J Cataract Refract Surg 2007; 33: 658-666. (Pubitemid 46482964)
12. Turner PL, Mainster MA. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol 2008; 92: 1439-1444.
13. Mainster MA, Turner PL. Blue-blocking IOLs decrease photoreception without providing significant photoprotection. Surv Ophthalmol 2010; 55: 272-283.
14. Hankins MW, Peirson SN, Foster RG. Melanopsin: an exciting new photopigment. Trends Neurosci 2008; 31: 27-36.
15. Mainster MA. Violet and blue light blocking intraocular lenses: Photoprotection versus photoreception. Br J Ophthamol 2006; 90: 784-792. (Pubitemid 43835502)
16. Landers JA, Tamblyn D, Perriam D. Effect of a blue-lightblocking intraocular lens on the quality of sleep. J Cataract Refract Surg 2009; 35: 83-88.
17. Espindle D, Crawford B, Maxwell A, Rajagopalan K, Barnes R, Harris B et al. Quality-of-life improvements in cataract patients with bilateral blue light-filtering intraocular lenses: clinical trial. J Cataract Refract Surg 2005; 31: 1952-1959. (Pubitemid 41773168)
18. Middleton B, Stone BM, Arendt J. Human circadian phase in 12:12 h, 200:o8 lux and 1000:o8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett 2002; 329: 41-44.